Registry Study on Rare Cancers in Korea
NCT06746766 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-04-30
Summary
This study aims to determine the participation rate of patients with registered rare cancers in clinical research.
Conditions
- Rare Cancer
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
Hyo Song Kim, MD, Ph.D · Yonsei Cencer center
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-18
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-01
Countries
- South Korea
Study Locations
More Related Trials
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
NCT01567046 ·Status: COMPLETED
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Medical Data Collection in the Formation of Precision Oncology Registry
NCT03874065 ·Status: TERMINATED
-
The Samsung Medical Center Comprehensive Cancer Center Registry from 2008 to 2023
NCT06703957 ·Status: COMPLETED
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids
NCT02546453 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
NCT03167476 ·Status: UNKNOWN
-
Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
NCT02015026 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
NCT00341146 ·Status: COMPLETED
-
Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer
NCT05541874 ·Status: NOT_YET_RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
NCT04690374 ·Status: RECRUITING
-
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
NCT06678724 ·Status: RECRUITING
-
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
NCT02330718 ·Status: UNKNOWN
-
What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors
NCT02840604 ·Status: COMPLETED
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
NCT02151747 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
NCT01345513 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152 ·Status: COMPLETED
-
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
NCT03739827 ·Status: RECRUITING